1Y Close · As of Aug 26, 2026
GFC Life Science operates in the Chemicals sector.
Legal name: GFC Life Science Co., Ltd.
In fiscal year 2025, GFC Life Science (388610) reported revenue of 17.7 billion KRW, up 5.4% from 16.8 billion KRW a year earlier.
Operating profit was 386 million KRW and net income was 555 million KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 29.1 billion KRW, with a P/B of 1.22.
These figures can be verified in the DART filing (receipt no. 20260318000998).
Recent Filings
Officer/Major Shareholder Ownership Report
Large Shareholding Report (General)
Record Date Setting
Checks
No items require attention at this time.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: Treasury stock filings in the last 3 years: 2 disposal(s), 1 cancellation(s).
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-27 | Officer/Major Shareholder Ownership Report |
| 2026-08-27 | Large Shareholding Report (General) |
| 2026-08-24 | Record Date Setting |
| 2026-08-24 | Share Retirement Decision |
| 2026-08-24 | Meeting Resolution (Extraordinary Meeting) |